CompoAtlas

Sommeil Nervosité

Food supplement declared in France, declaration No 2022-7-402, decision dated 7 July 2022

Sommeil Nervosité is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). 1 rule of use applies to its ingredients (limits and warnings).

Brand
not provided
Food business operator placing the product on the market
SANTISLAB FRANCE SAS
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Sirop
Daily dose
15 mL
Directions for use
Moins de 5 ans : 2 cuillères à café par jour. Plus de 5 ans : 3 cuillères à café par jour.
Not recommended for (according to the manufacturer)
Femmes allaitantes, Femmes enceintes
Objectives stated by the manufacturer (these are not authorised claims)
Sommeil

Declaration 234740, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Matricaria chamomilla L.FleurAutre extrait sec225 mg
Melissa officinalis L.FeuilleAutre extrait sec150 mg
Citrus aurantium L.FleurHydrolât (eau florale)90 mg
Tilia cordata Mill.FleurAutre extrait sec90 mg

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
Sels de magnésium de l'acide citriqueMagnésium250 mg300 mg
Chlorhydrate de pyridoxineVitamine B612 mg2 mg

Additives

E330, E415, E211, E202, E955

Other ingredients

Eau osmosée dynamisée

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

List recorded in 2022. Photograph the packaging to check whether it has changed. Photograph the packaging

Label warnings

Les femmes allaitantes doivent prendre l’attache d’un professionnel de santé avant toute complémentation.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

List recorded in 2022. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line